Strongyloides, cryptosporidium, and other parasitic infections

González, Iván; Stillwell, Terri

doi:10.1016/b978-0-323-64198-2.00041-5

Pediatric Transplant and Oncology Infectious Diseases 2021

DOI: 10.1016/b978-0-323-64198-2.00041-5

|View full text |Cite

Strongyloides, cryptosporidium, and other parasitic infections

Iván González¹,

Terri Stillwell²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2021

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Describing universal Strongyloides serologic screening among pediatric intestinal and liver transplant recipients

Chatani

Selvaggi

García

et al. 2021

Pediatric Transplantation

Self Cite

View full text Add to dashboard Cite

Background Strongyloides spp hyperinfections are a worldwide phenomenon that proves fatal for solid organ transplant recipients. Screening protocols to guide prophylaxis management vary institution to institution from universal to epidemiology driven. Our institution initiated a universal screening protocol regardless of travel history and exposure to ensure no cases were missed. Methods In this study, we describe the outcomes of three Strongyloides sero‐positive children whom underwent intestinal or liver transplantation and the experience of universal screening at a tertiary care county hospital in South Florida. Results Among the 66 intestine and liver pediatric transplant recipients who were screened for Strongyloides antibodies, only three were identified to be sero‐positive via the screening mechanism. Two of three had significant epidemiology risk factors. None of the patients reviewed were found to have developed hyperinfection. However, reflecting on the experience represented by our series of pediatric patients, the risk of any complication related to Strongyloides status appears low. Even among this South Florida population whom come from or travel to endemic regions are in contact with sero‐positive individuals, very few illustrate sero‐positivity. Conclusion While institutions continue to analyze the cost‐benefit of universal testing vs. universal prophylaxis vs. targeted screening, the decision must encompass the patient population, rolling cumulative incidence, and morbidity and mortality related to this disease.

show abstract

Describing universal Strongyloides serologic screening among pediatric intestinal and liver transplant recipients

Chatani

Selvaggi

García

et al. 2021

Pediatric Transplantation

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Strongyloides, cryptosporidium, and other parasitic infections

Cited by 1 publication

References 45 publications

Describing universal Strongyloides serologic screening among pediatric intestinal and liver transplant recipients

Describing universal Strongyloides serologic screening among pediatric intestinal and liver transplant recipients

Contact Info

Product

Resources

About